Yale Cancer Center – Immunotherapy Combination Shows Promise in Early Stage Triple Negative Breast Cancer

Some breast cancers are found to be triple negative, meaning that they are tested negative for estrogen receptors (ER-), progesterone receptors (PR-), and HER2 (HER2-). “A Yale Cancer Center clinical trial combining the immune checkpoint inhibitor (durvalumab/MEDI4736) with chemotherapy as preoperative treatment for early stage triple negative breast cancer showed a 71% pathologic complete response […]

Read More Yale Cancer Center – Immunotherapy Combination Shows Promise in Early Stage Triple Negative Breast Cancer

Checkpoint Inhibitors Advancing in Multiple GI Cancers – Gastroenterology & Endoscopy News

Immunotherapy is already used in a variety of different cancers with great success , and clinical trials are ongoing to test different approaches. Checkpoint inhibitors, specifically agents targeting programmed death-1 (PD-1), are being studied in clinical trials in a number of gastrointestinal tumors, including dMMR/MSI-H tumors which are associated with upregulated expression of checkpoint regulators […]

Read More Checkpoint Inhibitors Advancing in Multiple GI Cancers – Gastroenterology & Endoscopy News

Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient. – PubMed – NCBI

  Personalized treatment strategies are becoming more and more important, and can induce astonishing results where conventional treatments are limited, even in cancers with very poor prognosis, such as cholangiocarcinoma. Read here about the use of a personalized vaccination strategy used in a cholangiocarcinoma patient-who remains without detectable tumor lesions. Tumor tissue was analyzed by […]

Read More Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient. – PubMed – NCBI

Hallwang Clinic GmbH

Die Hallwang Private Oncology Clinic im wunderschönen Nordschwarzwald verfügt über 16 stationäre Betten, 2 Luxus-Suiten sowie 6 umliegende Apartments. In unserer Klinik betreuen wir überwiegend Patienten mit hämato-/onkologischen Grunderkrankungen in einem exquisiten privatonkologischem Umfeld und Behandlungskonzept. Im Fokus unserer Kliniktätigkeit steht die stationäre und ambulante Betreuung von internationalen Privatpatienten. Das diagnostische und therapeutische Leistungsspektrum erstreckt […]

Read More Hallwang Clinic GmbH